NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
ELTX Elicio Therapeutics
- 4.880
- -0.195-3.84%
Close Dec 20 16:00 ET
52.66MMarket Cap-1.12P/E (TTM)
5.020High4.700Low25.35KVolume5.000Open5.075Pre Close122.81KTurnover0.30%Turnover RatioLossP/E (Static)10.79MShares11.45052wk High-2.77P/B41.05MFloat Cap2.96052wk Low--Dividend TTM8.41MShs Float263.000Historical High--Div YieldTTM6.31%Amplitude2.960Historical Low4.845Avg Price1Lot Size
About Elicio Therapeutics Company
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
Company Profile
SymbolELTX
Company NameElicio Therapeutics
Listing DateFeb 5, 2021
Founded2011
CEOMr. Robert Connelly
MarketNASDAQ
Employees32
Fiscal Year Ends12-31
Address451 D Street,5th floor, Suite 501
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-209-0050
Websitehttp://www.elicio.com
Company Executives
- Name
- Position
- Salary
- Robert Connelly
- Chief Executive Officer, President, Director, Principal Accounting Officer and Principal Financial Officer
- 678.30K
- Dr. Christopher Haqq, M.D.,PhD
- Executive Vice President, Head of Research and Development and Chief Medical Officer
- 673.82K
- Dr. Peter DeMuth, PhD
- Chief Scientific Officer
- --
- Dr. Julian Ada PhD
- Chairman of the Board
- 96.05K
- Yekaterina Chudnovsky
- Director
- 48.68K
- Dr. Jay R. Venkatesan, M.D.
- Director
- 45.76K
- Dr. Robert R. Ruffolo, Jr, Ph.D
- Independent Director
- 63.26K
- Dr. Allen R. Nissenson,M.D.
- Independent Director
- 91.22K
- Karen J. Wilson
- Independent Director
- 101.02K
- Carol Gail Ashe
- Independent Director
- 71.59K
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.